In order to augment the Covid-19 vaccine production capacity in our country so that a significant percentage of the population can get vaccinated at the earliest, the Central Government requested that Indian Immunologicals Limited (IIL) and Bharat Bi ...
Bharat Biotech International Limited on Friday confirmed that the company has signed an agreement with Brazil for the supply of 20 million doses of Covaxin vaccine. ...
Bharat Biotech International Limited on Friday confirmed that the company has signed an agreement with Brazil for the supply of 20 million doses of Covaxin vaccine. ...
The Bharat Biotech International Limited (BBIL) has announced the successful air-shipment of its COVID-19 vaccine 'Covaxin' to 11 cities in the country in the early hours of Wednesday. ...
The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday. ...
The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.' ...
The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI. ...